D-dimer strategy in thrombosis exclusion--a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD methods compared

Thromb Haemost. 1998 Jan;79(1):32-7.


DD are now recognized as a valuable tool to screen patients suspected of deep venous thrombosis or pulmonary embolism before carrying out a gold standard radiologic examination. The newest methods available claim to be able to ascertain the absence of thrombosis, but they have yet to prove their efficiency. We compared the performances of 3 reference ELISA methods (D-DI Asserachrom Stago, D-dimer Enzygnost Behring and Dimertest GOLD EIA Agen), 5 recent rapid methods (VIDAS D-Dimer bioMérieux, Instant IA Stago, Simplired Agen, Nycocard D-dimer Nycomed and Accuclot D-Dimer Sigma Diagnostics) and two routine latex methods (Dimertest American Diagnostica and FDP-Slidex bioMérieux) in 100 patients. One of the rapid quantitative methods was demonstrated to have a level of efficiency comparable to that of ELISA methods. Finally, the cost and efficiency of different strategies were evaluated, the association of a routine latex method with the VIDAS D-Dimer bioMérieux being proven to be the most efficient.

MeSH terms

  • Adult
  • Clinical Laboratory Techniques
  • Diagnosis, Differential
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Humans
  • Male
  • Mass Screening / methods*
  • Middle Aged
  • Predictive Value of Tests
  • Pulmonary Embolism / blood
  • Pulmonary Embolism / diagnosis*
  • Radiography
  • Reference Standards
  • Thrombophlebitis / blood
  • Thrombophlebitis / diagnosis*
  • Thrombophlebitis / diagnostic imaging


  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D